Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Clinical implications of Brief Psychiatric Rating Scale scores.

Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R.

Br J Psychiatry. 2005 Oct;187:366-71.

2.

Linking the PANSS, BPRS, and CGI: clinical implications.

Leucht S, Kane JM, Etschel E, Kissling W, Hamann J, Engel RR.

Neuropsychopharmacology. 2006 Oct;31(10):2318-25. Epub 2006 Jul 5.

3.

Equipercentile linking of the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in a catchment area.

Leucht S, Engel RR, Davis JM, Kissling W, Meyer Zur Capellen K, Schmauß M, Messer T.

Eur Neuropsychopharmacol. 2012 Jul;22(7):501-5. doi: 10.1016/j.euroneuro.2011.11.007. Epub 2012 Mar 3.

PMID:
22386773
4.

Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms.

Levine SZ, Leucht S.

Schizophr Res. 2013 Apr;145(1-3):125-7. doi: 10.1016/j.schres.2012.12.032. Epub 2013 Feb 8.

PMID:
23394742
5.

What does the PANSS mean?

Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR.

Schizophr Res. 2005 Nov 15;79(2-3):231-8. Epub 2005 Jun 27.

PMID:
15982856
6.

Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.

Levine SZ, Rabinowitz J, Engel R, Etschel E, Leucht S.

Schizophr Res. 2008 Jan;98(1-3):318-22. Epub 2007 Oct 18.

PMID:
17949948
7.

Equipercentile linking of the BPRS and the PANSS.

Leucht S, Rothe P, Davis JM, Engel RR.

Eur Neuropsychopharmacol. 2013 Aug;23(8):956-9. doi: 10.1016/j.euroneuro.2012.11.004. Epub 2013 Feb 22.

PMID:
23433639
8.

Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.

Takahashi H, Kamata M, Yoshida K, Ishigooka J, Higuchi H.

J Clin Psychiatry. 2006 Oct;67(10):1577-82.

PMID:
17107250
9.

Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.

Molina JD, Toledo-Romero F, López-Rodríguez E, Amorin-Díaz M, Lerma-Carrillo I, López-Muñoz F.

Pharmacopsychiatry. 2011 Jun;44(4):142-7. doi: 10.1055/s-0031-1279728. Epub 2011 Jun 27.

PMID:
21710404
10.
11.

What does the HAMD mean?

Leucht S, Fennema H, Engel R, Kaspers-Janssen M, Lepping P, Szegedi A.

J Affect Disord. 2013 Jun;148(2-3):243-8. doi: 10.1016/j.jad.2012.12.001. Epub 2013 Jan 26.

PMID:
23357658
12.

Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.

Lee J, Fervaha G, Takeuchi H, Powell V, Remington G.

J Clin Psychopharmacol. 2015 Jun;35(3):237-41. doi: 10.1097/JCP.0000000000000310.

PMID:
25839337
13.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196
14.

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.

Alvarez E, Bobes J, Gómez JC, Sacristán JA, Cañas F, Carrasco JL, Gascón J, Gibert J, Gutiérrez M; EUROPA Study Group.

Eur Neuropsychopharmacol. 2003 Jan;13(1):39-48.

PMID:
12480121
15.

Clinical relevance of findings in trials of antipsychotics: systematic review.

Lepping P, Sambhi RS, Whittington R, Lane S, Poole R.

Br J Psychiatry. 2011 May;198(5):341-5. doi: 10.1192/bjp.bp.109.075366. Review.

16.

Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia--a study group report.

Delini-Stula A, Berdah-Tordjman D.

J Psychiatr Res. 1996 Jul-Aug;30(4):239-50.

PMID:
8905533
17.
18.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
19.

Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.

Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O; Amisulpride Study Group.

J Clin Psychopharmacol. 2002 Dec;22(6):554-60.

PMID:
12454554
20.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241

Supplemental Content

Support Center